Troy Edward Wilson - 08 Sep 2025 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role: President & CEO, Director
Signature: /s/ Teresa Bair, Attorney-in-fact for Troy E. Wilson
Issuer symbol: KURA
Transactions as of: 08 Sep 2025
Net transactions value: +$410,145
Form type: 4
Filing time: 09 Sep 2025, 16:28:40 UTC
Previous filing: 09 Sep 2025
Next filing: 29 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
WILSON TROY EDWARD	President & CEO, Director	C/O KURA ONCOLOGY, INC., 12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO	/s/ Teresa Bair, Attorney-in-fact for Troy E. Wilson	09 Sep 2025	0001589597

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KURA	Common Stock	Purchase	$410,145	+50,000	+98%	$8.20	100,968	08 Sep 2025	Direct	F1
holding	KURA	Common Stock						279,194	08 Sep 2025	by One Fish Two Fish Revocable Trust
holding	KURA	Common Stock						300,000	08 Sep 2025	by Lorax Charitable Remainder Unitrust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $8.135 to $8.24. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakesto provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.